Business ❯ Pharmaceuticals ❯ Drug Development

Clinical Research

Regulatory Affairs Japanese Pharmaceutical Companies Phase 3 Trials FDA Approvals Neurocrine Biosciences AstraZeneca Funding Sources Radiopharmaceuticals Wave Life Sciences Pharmaceutical Industry Trends Monoclonal Antibodies

Summit Therapeutics Shares Rally as Ivonescimab Trials Near Q2 Readout

Investor interest reflects looming data that could shape the drug’s path through FDA review.

Edgewise Reports Favorable Interim Safety in Phase 2 HCM Trial of EDG-7500

Neurocrine’s Valbenazine Misses Phase 3 Goals in Dyskinetic Cerebral Palsy

Datroway Extends Survival Over Chemotherapy in First-Line TNBC Ineligible for Immunotherapy

Study Finds Most With New Focal Epilepsy Need a Year to Gain Seizure Control